We will be glad to help and assist you in finding the crossword clues for the following clue: Give over.
looking at this crossword definition, it has 9 letters.
for better and easier way of searching the for a crossword clue, try using the search term “Give over crossword” or “Give over crossword clue” while searching and trying to find help in finishing your crosswords. Here are the possible answers for Give over.
We hope you found what you needed!
If you are still unsure with some definitions, don’t hesitate to search for them here in our site using the search box on top.
Possible Answers:
CEDE.
Last seen on: Wall Street Journal Crossword – October 04 2022 – Call the Cops
Random information on the term “CEDE”:
Thorotrast is a suspension containing particles of the radioactive compound thorium dioxide, ThO2; it was used as a radiocontrast agent in clinical radiography in the 1930s to 1950s. It is no longer used clinically.
Thorium compounds produce excellent images because of thorium’s high opacity to X-rays (it has a high cross section for absorption). However, thorium is retained in the body, and it is radioactive, emitting harmful alpha radiation as it decays. Because the suspension offered high image quality and had virtually no immediate side-effects compared to the alternatives available at the time, Thorotrast became widely used after its introduction in 1931. António Egas Moniz contributed to its development. About 2 to 10 million patients worldwide have been treated with Thorotrast. However, today it has shown an increase risk in certain cancers such as cholangiocarcinomas, angiosarcomas, hepatocellular carcinoma and hepatic fibrosis of the liver.
Even at the time of introduction, there was concern about the safety of Thorotrast. Following injection, the drug is distributed to the liver, spleen, lymph nodes, and bone, where it is absorbed. After this initial absorption, redistribution takes place at a very slow pace. Specifically, the biological half-life is estimated to be 22 years. This means that the organs of patients who have been given Thorotrast will be exposed to internal alpha radiation for the rest of their lives. The significance of this long-term exposure was not fully understood at the time of Thorotrast’s introduction in 1931.